JP2019510202A - 多重パラメータ分光法のためのシステム及び方法 - Google Patents
多重パラメータ分光法のためのシステム及び方法 Download PDFInfo
- Publication number
- JP2019510202A JP2019510202A JP2018536888A JP2018536888A JP2019510202A JP 2019510202 A JP2019510202 A JP 2019510202A JP 2018536888 A JP2018536888 A JP 2018536888A JP 2018536888 A JP2018536888 A JP 2018536888A JP 2019510202 A JP2019510202 A JP 2019510202A
- Authority
- JP
- Japan
- Prior art keywords
- oam
- sample
- spectroscopic
- output signal
- light beam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004611 spectroscopical analysis Methods 0.000 title claims abstract description 145
- 238000000034 method Methods 0.000 title claims description 106
- 239000000126 substance Substances 0.000 claims abstract description 157
- 238000004458 analytical method Methods 0.000 claims abstract description 30
- 238000001069 Raman spectroscopy Methods 0.000 claims description 164
- 230000003287 optical effect Effects 0.000 claims description 102
- 230000010287 polarization Effects 0.000 claims description 71
- 238000001514 detection method Methods 0.000 claims description 51
- 238000010521 absorption reaction Methods 0.000 claims description 26
- 230000005284 excitation Effects 0.000 claims description 20
- 230000005855 radiation Effects 0.000 claims description 17
- 238000004566 IR spectroscopy Methods 0.000 claims description 15
- 238000000295 emission spectrum Methods 0.000 claims description 13
- 238000001506 fluorescence spectroscopy Methods 0.000 claims description 12
- 230000004044 response Effects 0.000 claims description 12
- 230000009977 dual effect Effects 0.000 claims description 11
- 230000001427 coherent effect Effects 0.000 claims description 7
- 238000000695 excitation spectrum Methods 0.000 claims description 7
- 210000001520 comb Anatomy 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 230000005428 wave function Effects 0.000 claims description 5
- 238000002455 polarised Raman spectroscopy Methods 0.000 claims description 4
- 238000012844 infrared spectroscopy analysis Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 238
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 80
- 239000008103 glucose Substances 0.000 description 80
- 239000013598 vector Substances 0.000 description 56
- 239000000463 material Substances 0.000 description 55
- 230000003993 interaction Effects 0.000 description 46
- 235000013305 food Nutrition 0.000 description 44
- 238000005259 measurement Methods 0.000 description 41
- 239000000306 component Substances 0.000 description 36
- 238000010586 diagram Methods 0.000 description 33
- 239000000243 solution Substances 0.000 description 33
- 230000008859 change Effects 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 29
- 239000008280 blood Substances 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 238000001228 spectrum Methods 0.000 description 25
- 230000008569 process Effects 0.000 description 24
- 239000013078 crystal Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 238000012306 spectroscopic technique Methods 0.000 description 19
- 230000007704 transition Effects 0.000 description 19
- 238000011161 development Methods 0.000 description 18
- 230000018109 developmental process Effects 0.000 description 18
- 206010012601 diabetes mellitus Diseases 0.000 description 18
- 230000006870 function Effects 0.000 description 18
- 238000003384 imaging method Methods 0.000 description 17
- 230000006378 damage Effects 0.000 description 16
- 230000008901 benefit Effects 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 14
- 239000007787 solid Substances 0.000 description 13
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 12
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 12
- 238000009826 distribution Methods 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 11
- 125000004429 atom Chemical group 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 11
- 230000005684 electric field Effects 0.000 description 11
- 230000005283 ground state Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 238000001237 Raman spectrum Methods 0.000 description 9
- 238000000862 absorption spectrum Methods 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000002269 spontaneous effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 238000002329 infrared spectrum Methods 0.000 description 8
- 238000010905 molecular spectroscopy Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 230000003595 spectral effect Effects 0.000 description 8
- 238000013519 translation Methods 0.000 description 8
- 230000014616 translation Effects 0.000 description 8
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 7
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 7
- 230000005281 excited state Effects 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 238000005452 bending Methods 0.000 description 6
- 239000000090 biomarker Substances 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000005672 electromagnetic field Effects 0.000 description 6
- 230000036252 glycation Effects 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000000711 polarimetry Methods 0.000 description 6
- 239000004065 semiconductor Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000005274 electronic transitions Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000001945 resonance Rayleigh scattering spectroscopy Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000001328 terahertz time-domain spectroscopy Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 239000002178 crystalline material Substances 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000002594 fluoroscopy Methods 0.000 description 4
- 239000004973 liquid crystal related substance Substances 0.000 description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 4
- 235000012661 lycopene Nutrition 0.000 description 4
- 229960004999 lycopene Drugs 0.000 description 4
- 239000001751 lycopene Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000001902 propagating effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000004497 NIR spectroscopy Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000003841 Raman measurement Methods 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000000149 argon plasma sintering Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- -1 coporphyrin Chemical compound 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 235000012489 doughnuts Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 108091005995 glycated hemoglobin Proteins 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000013139 quantization Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000003851 biochemical process Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 108091005996 glycated proteins Proteins 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000006609 metabolic stress Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 238000002095 near-infrared Raman spectroscopy Methods 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 238000012634 optical imaging Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000010363 phase shift Effects 0.000 description 2
- 238000005424 photoluminescence Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- 230000000979 retarding effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001774 stimulated Raman spectroscopy Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000002887 superconductor Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- PGNRLPTYNKQQDY-UHFFFAOYSA-N 2,3-dihydroxyindole Chemical compound C1=CC=C2C(O)=C(O)NC2=C1 PGNRLPTYNKQQDY-UHFFFAOYSA-N 0.000 description 1
- MOTVYDVWODTRDF-UHFFFAOYSA-N 3-[7,12,17-tris(2-carboxyethyl)-3,8,13,18-tetrakis(carboxymethyl)-21,22-dihydroporphyrin-2-yl]propanoic acid Chemical compound N1C(C=C2C(=C(CC(O)=O)C(=CC=3C(=C(CC(O)=O)C(=C4)N=3)CCC(O)=O)N2)CCC(O)=O)=C(CC(O)=O)C(CCC(O)=O)=C1C=C1C(CC(O)=O)=C(CCC(=O)O)C4=N1 MOTVYDVWODTRDF-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- LOOZJFQSKPUFDU-UHFFFAOYSA-N CC(C)C(N=N)O Chemical compound CC(C)C(N=N)O LOOZJFQSKPUFDU-UHFFFAOYSA-N 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 101100457838 Caenorhabditis elegans mod-1 gene Proteins 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 230000005483 Hooke's law Effects 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241000143252 Idaea infirmaria Species 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 101150110972 ME1 gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241000605861 Prevotella Species 0.000 description 1
- 241001135225 Prevotella nigrescens Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- CTCBPRXHVPZNHB-VQFZJOCSSA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O CTCBPRXHVPZNHB-VQFZJOCSSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000035559 beat frequency Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011697 diabetes animal model Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001413 far-infrared spectroscopy Methods 0.000 description 1
- 235000020937 fasting conditions Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 235000015219 food category Nutrition 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108010004903 glycosylated serum albumin Proteins 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 238000000651 laser trapping Methods 0.000 description 1
- 230000004298 light response Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000004476 mid-IR spectroscopy Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000012014 optical coherence tomography Methods 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 238000001874 polarisation spectroscopy Methods 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000010801 sewage sludge Substances 0.000 description 1
- 239000005361 soda-lime glass Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- WGPCGCOKHWGKJJ-UHFFFAOYSA-N sulfanylidenezinc Chemical compound [Zn]=S WGPCGCOKHWGKJJ-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000005010 torso Anatomy 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0205—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows
- G01J3/021—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows using plane or convex mirrors, parallel phase plates, or particular reflectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0205—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows
- G01J3/0224—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows using polarising or depolarising elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0205—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows
- G01J3/0229—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows using masks, aperture plates, spatial light modulators or spatial filters, e.g. reflective filters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/2803—Investigating the spectrum using photoelectric array detector
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/30—Measuring the intensity of spectral lines directly on the spectrum itself
- G01J3/36—Investigating two or more bands of a spectrum by separate detectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/21—Polarisation-affecting properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3581—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N2021/1734—Sequential different kinds of measurements; Combining two or more methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
- G01N2021/655—Stimulated Raman
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3581—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation
- G01N21/3586—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation by Terahertz time domain spectroscopy [THz-TDS]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/636—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited using an arrangement of pump beam and probe beam; using the measurement of optical non-linear properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/067—Electro-optic, magneto-optic, acousto-optic elements
- G01N2201/0675—SLM
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Spectrometry And Color Measurement (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662278186P | 2016-01-13 | 2016-01-13 | |
US62/278,186 | 2016-01-13 | ||
US201662322507P | 2016-04-14 | 2016-04-14 | |
US62/322,507 | 2016-04-14 | ||
US201662365486P | 2016-07-22 | 2016-07-22 | |
US62/365,486 | 2016-07-22 | ||
PCT/US2017/013408 WO2017123926A1 (fr) | 2016-01-13 | 2017-01-13 | Système et procédé de spectroscopie à paramètres multiples |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2019510202A true JP2019510202A (ja) | 2019-04-11 |
Family
ID=59312138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018536888A Pending JP2019510202A (ja) | 2016-01-13 | 2017-01-13 | 多重パラメータ分光法のためのシステム及び方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3403067A4 (fr) |
JP (1) | JP2019510202A (fr) |
CN (1) | CN108780042A (fr) |
WO (1) | WO2017123926A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210016319A (ko) * | 2019-07-31 | 2021-02-15 | 칭화대학교 | 비침습 혈당 측정기 및 혈당 측정 방법 |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11896461B2 (en) | 2018-06-22 | 2024-02-13 | Align Technology, Inc. | Intraoral 3D scanner employing multiple miniature cameras and multiple miniature pattern projectors |
CN111272728B (zh) * | 2018-12-05 | 2021-09-03 | 同济大学 | 一种手性化合物的检测方法 |
CN113574438B (zh) * | 2019-02-03 | 2023-07-18 | 巴伊兰大学 | 通过散射介质成像的系统及方法 |
CN110208212B (zh) * | 2019-07-04 | 2021-06-18 | 中南林业科技大学 | 一种近红外光谱全方位无损检测装置及控制方法 |
CN110553982A (zh) * | 2019-08-29 | 2019-12-10 | 安徽科技学院 | 一种偏振高光谱图像采集系统 |
CN111855567B (zh) * | 2019-10-16 | 2021-07-20 | 中国科学院物理研究所 | 一种实现光学智能聚焦的透射电镜系统及方法 |
CN112782146B (zh) * | 2019-11-11 | 2022-11-04 | 中国石油天然气股份有限公司 | 一种基于拉曼光谱的汽油烯烃含量分析方法 |
CN110811615A (zh) * | 2019-11-20 | 2020-02-21 | 中国科学院电子学研究所 | 基于螺旋相衬成像的太赫兹成像方法及装置 |
CN111007007A (zh) * | 2019-11-30 | 2020-04-14 | 中国船舶重工集团公司第七一七研究所 | 一种可切换红外光谱偏振成像装置及其测量方法 |
CN111157109A (zh) * | 2020-01-10 | 2020-05-15 | 中国计量大学 | 一种基于等效张量重构法的关联涡旋识别装置 |
CN111209524B (zh) * | 2020-01-14 | 2023-09-22 | 西安理工大学 | 一种拓扑绝缘体粒子对涡旋光散射特性的计算方法 |
CN111257957B (zh) * | 2020-02-25 | 2021-06-01 | 西安交通大学 | 基于被动式太赫兹成像的识别跟踪系统及方法 |
CN111380840B (zh) * | 2020-03-13 | 2023-07-14 | 西安理工大学 | 石墨烯材料激光装置及检测石墨烯光学特性的方法 |
CN111721231B (zh) * | 2020-06-03 | 2021-11-19 | 华东师范大学 | 一种基于光频梳的植物生态监测系统 |
US20230277063A1 (en) * | 2020-08-07 | 2023-09-07 | Endectra, Llc | Wearable spectrometer for biomolecule interrogation in biological tissue |
CN111912931A (zh) * | 2020-08-10 | 2020-11-10 | 燕山大学 | 基于四元数主成分分析的tlc-sers定量建模方法 |
CN112179874B (zh) * | 2020-09-29 | 2021-11-19 | 华中科技大学 | 一种发光材料激子取向的测量方法及装置 |
CN112378858B (zh) * | 2020-11-11 | 2021-08-20 | 上海交通大学 | 一种手性探测系统 |
CN112540416B (zh) * | 2020-12-01 | 2022-01-28 | 中国工程物理研究院激光聚变研究中心 | 一种太赫兹脉冲上转换探测方法及系统 |
CN112557325A (zh) * | 2020-12-08 | 2021-03-26 | 塔里木大学 | 一种果树果品品质近地面遥感监测装置和方法 |
US11988746B2 (en) * | 2020-12-24 | 2024-05-21 | Waymo Llc | Multi-axis velocity and rangefinder optical measurement device |
CN112964665B (zh) * | 2021-02-04 | 2023-02-17 | 中国科学院重庆绿色智能技术研究院 | 一种基于高分辨太赫兹技术的肿瘤标志物分子检测系统 |
CN113109318B (zh) * | 2021-03-26 | 2022-05-10 | 中国科学院西安光学精密机械研究所 | 基于光谱峰高直接提取的拉曼光谱定量分析方法及系统 |
CN113465887B (zh) * | 2021-06-24 | 2022-05-20 | 华中科技大学 | 一种发光器件激子特性参数反演方法及装置 |
CN113534475B (zh) * | 2021-07-21 | 2022-11-08 | 上海理工大学 | 产生贝塞尔时空波包及贝塞尔时空涡旋波包的方法 |
CN113777075B (zh) * | 2021-09-07 | 2022-10-14 | 电子科技大学 | 基于光场霍尔效应及轨道角动量谱的浓度测量方法 |
CN113777068B (zh) * | 2021-09-13 | 2023-07-18 | 国网四川省电力公司电力科学研究院 | 一种多波段腔增强红外光梳光谱气体检测系统 |
CN113884448A (zh) * | 2021-09-29 | 2022-01-04 | 深圳市比特原子科技有限公司 | 水中溶解性总固体和氢离子浓度的检测装置及检测方法 |
CN114584214B (zh) * | 2021-12-30 | 2024-03-15 | 山东师范大学 | 一种基于复合涡旋光束的编码光通信方法及系统 |
CN114993965B (zh) * | 2022-05-13 | 2023-04-18 | 中煤嘉沣(湖南)环保科技有限责任公司 | 一种污染源自动识别方法以及系统 |
CN115356264A (zh) * | 2022-08-12 | 2022-11-18 | 大连理工大学 | 一种硅片中位裂纹与侧位裂纹分离化检测方法 |
CN117665950B (zh) * | 2024-01-31 | 2024-04-02 | 四川阳光上元科技有限公司 | 基于量粒子的瓦斯富集区探测方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007092009A2 (fr) * | 2005-02-09 | 2007-08-16 | Chemimage Corporation | Système et procédé de dépôt, de détection et d'identification d'agents de menace |
WO2007149534A2 (fr) * | 2006-06-21 | 2007-12-27 | University Of Dayton | Procédés d'ingénierie de polarisation et leurs applications |
WO2010004720A1 (fr) * | 2008-07-09 | 2010-01-14 | 国立大学法人 東京工業大学 | Microspectroscope |
US20100122407A1 (en) * | 2008-11-18 | 2010-05-20 | Cover-Pools Incorporated | Methods, apparatus and kits for splicing tubes |
WO2011062842A1 (fr) * | 2009-11-18 | 2011-05-26 | The Regents Of The University Of California | Appareil et procédé pour spectroscopie raman stimulée impulsive à multiples impulsions |
JP2011107094A (ja) * | 2009-11-20 | 2011-06-02 | Mitsubishi Heavy Ind Ltd | 配管中のガス成分計測装置及び排ガス成分計測用煙道 |
WO2012122151A1 (fr) * | 2011-03-08 | 2012-09-13 | Horiba Instruments Incorporated | Système et procédé d'analyse par fluorescence et absorbance |
WO2015045266A1 (fr) * | 2013-09-24 | 2015-04-02 | 国立大学法人東京農工大学 | Dispositif de mesure |
WO2015138239A1 (fr) * | 2014-03-12 | 2015-09-17 | Solyman Ashrafi | Mesures de concentration d'échantillon à l'aide d'un moment angulaire orbital |
US20150289766A1 (en) * | 2014-04-09 | 2015-10-15 | Solyman Ashrafi | Orbital angular momentum and fluorescence-based microendoscope spectroscopy for cancer diagnosis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3893771A (en) * | 1974-08-22 | 1975-07-08 | Diax Corp | Laser absorption spectroscopy |
AU2003285815A1 (en) * | 2002-12-02 | 2004-06-23 | Erasmus Universiteit Rotterdam | Use of high wavenumber raman spectroscopy for measuring tissue |
US7046359B2 (en) * | 2004-06-30 | 2006-05-16 | Chemimage Corporation | System and method for dynamic chemical imaging |
US7532320B2 (en) * | 2004-06-30 | 2009-05-12 | Chemimage Corporation | Multimodal method for identifying hazardous agents |
WO2006019776A2 (fr) * | 2004-07-14 | 2006-02-23 | William Marsh Rice University | Procede de couplage d'impulsions terahertz dans un guide d'ondes coaxial |
JP5035618B2 (ja) * | 2006-12-05 | 2012-09-26 | 独立行政法人理化学研究所 | 電磁波を用いた検出方法、及び検出装置 |
US10059975B2 (en) * | 2008-10-31 | 2018-08-28 | Biomerieux, Inc. | Methods for the isolation and identification of microorganisms |
US8384990B2 (en) * | 2009-08-12 | 2013-02-26 | The Board Of Trustees Of The Leland Stanford Junior University | Infrared frequency comb methods, arrangements and applications |
US8653462B2 (en) * | 2010-04-27 | 2014-02-18 | Rensselaer Polytechnic Institute | Methods and systems for detecting terahertz radiation by radiation enhanced emission of fluorescence |
WO2012103289A1 (fr) * | 2011-01-27 | 2012-08-02 | Trustees Of Boston University | Dispositifs optiques dotés de structures apériodiques en spirale pour une diffusion circulairement symétrique de la lumière |
-
2017
- 2017-01-13 JP JP2018536888A patent/JP2019510202A/ja active Pending
- 2017-01-13 WO PCT/US2017/013408 patent/WO2017123926A1/fr active Application Filing
- 2017-01-13 EP EP17739034.1A patent/EP3403067A4/fr not_active Withdrawn
- 2017-01-13 CN CN201780016835.8A patent/CN108780042A/zh active Pending
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008533448A (ja) * | 2005-02-09 | 2008-08-21 | ケムイメージ コーポレイション | 脅威物質を検出及び識別するシステム及び方法 |
WO2007092009A2 (fr) * | 2005-02-09 | 2007-08-16 | Chemimage Corporation | Système et procédé de dépôt, de détection et d'identification d'agents de menace |
EP1880189A2 (fr) * | 2005-02-09 | 2008-01-23 | Chemimage Corporation | Système et procédé de dépôt, de détection et d'identification d'agents de menace |
US20080151223A1 (en) * | 2005-02-09 | 2008-06-26 | Treado Patrick J | System and method for the deposition, detection and identification of threat agents using a fiber array spectral translator |
US20100141939A1 (en) * | 2006-06-21 | 2010-06-10 | University Of Dayton | Methods of polarization engineering and their applications |
JP2009541742A (ja) * | 2006-06-21 | 2009-11-26 | ユニバーシティ・オブ・デイトン | 偏光設計の方法およびそれらの適用例 |
WO2007149534A2 (fr) * | 2006-06-21 | 2007-12-27 | University Of Dayton | Procédés d'ingénierie de polarisation et leurs applications |
EP2038894A2 (fr) * | 2006-06-21 | 2009-03-25 | University Of Dayton | Procédés d'ingénierie de polarisation et leurs applications |
WO2010004720A1 (fr) * | 2008-07-09 | 2010-01-14 | 国立大学法人 東京工業大学 | Microspectroscope |
JP2010019630A (ja) * | 2008-07-09 | 2010-01-28 | Tokyo Institute Of Technology | 顕微分光装置 |
US20100122407A1 (en) * | 2008-11-18 | 2010-05-20 | Cover-Pools Incorporated | Methods, apparatus and kits for splicing tubes |
JP2013511718A (ja) * | 2009-11-18 | 2013-04-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 多重パルスインパルシブ誘導ラマン分光装置および測定方法 |
WO2011062842A1 (fr) * | 2009-11-18 | 2011-05-26 | The Regents Of The University Of California | Appareil et procédé pour spectroscopie raman stimulée impulsive à multiples impulsions |
JP2011107094A (ja) * | 2009-11-20 | 2011-06-02 | Mitsubishi Heavy Ind Ltd | 配管中のガス成分計測装置及び排ガス成分計測用煙道 |
WO2012122151A1 (fr) * | 2011-03-08 | 2012-09-13 | Horiba Instruments Incorporated | Système et procédé d'analyse par fluorescence et absorbance |
US20120228519A1 (en) * | 2011-03-08 | 2012-09-13 | Horiba Jobin Yvon Inc. | System and Method for Fluorescence and Absorbance Analysis |
EP2684031A1 (fr) * | 2011-03-08 | 2014-01-15 | Horiba Instruments Incorporated | Système et procédé d'analyse par fluorescence et absorbance |
JP2014510915A (ja) * | 2011-03-08 | 2014-05-01 | ホリバ インスツルメンツ インコーポレイテッド | 蛍光および吸収分析のシステムおよび方法 |
WO2015045266A1 (fr) * | 2013-09-24 | 2015-04-02 | 国立大学法人東京農工大学 | Dispositif de mesure |
WO2015138239A1 (fr) * | 2014-03-12 | 2015-09-17 | Solyman Ashrafi | Mesures de concentration d'échantillon à l'aide d'un moment angulaire orbital |
US20150289766A1 (en) * | 2014-04-09 | 2015-10-15 | Solyman Ashrafi | Orbital angular momentum and fluorescence-based microendoscope spectroscopy for cancer diagnosis |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210016319A (ko) * | 2019-07-31 | 2021-02-15 | 칭화대학교 | 비침습 혈당 측정기 및 혈당 측정 방법 |
KR102332190B1 (ko) * | 2019-07-31 | 2021-12-02 | 칭화대학교 | 비침습 혈당 측정기 및 혈당 측정 방법 |
US11759129B2 (en) | 2019-07-31 | 2023-09-19 | Tsinghua University | Noninvasive glucometer and blood glucose detection method |
Also Published As
Publication number | Publication date |
---|---|
EP3403067A4 (fr) | 2019-08-28 |
WO2017123926A1 (fr) | 2017-07-20 |
CN108780042A (zh) | 2018-11-09 |
EP3403067A1 (fr) | 2018-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11002677B2 (en) | System and method for multi-parameter spectroscopy | |
JP2019510202A (ja) | 多重パラメータ分光法のためのシステム及び方法 | |
US10006859B2 (en) | System and method for multi-parameter spectroscopy | |
US10209192B2 (en) | Spectroscopy with correlation matrices, ratios and glycation | |
US10048202B2 (en) | System and method for detection of materials using orbital angular momentum signatures | |
US10082463B2 (en) | System and method for making concentration measurements within a sample material using orbital angular momentum | |
Smye et al. | The interaction between terahertz radiation and biological tissue | |
US11701441B2 (en) | Miniaturized device to sterilize surfaces from Covid-19 and other viruses | |
Weida et al. | Quantum cascade laser-based replacement for FTIR microscopy | |
Gardner et al. | Non-invasive chemically specific measurement of subsurface temperature in biological tissues using surface-enhanced spatially offset Raman spectroscopy | |
Korolevich et al. | Experimental study of the potential use of diffusing wave spectroscopy to investigate the structural characteristics of blood under multiple scattering | |
Bakopoulos et al. | A tunable continuous wave (CW) and short-pulse optical source for THz brain imaging applications | |
WO2022011133A1 (fr) | Dispositif miniaturisé pour stériliser des surfaces contre la covid-19 et d'autres virus | |
Parham et al. | Wavelength-swept spontaneous Raman spectroscopy system improves fiber-based collection efficiency for whole brain tissue classification | |
Zhu et al. | Time-resolved vibrational dynamics: Novel opportunities for sensing and imaging | |
ALMUHAWISH | Materials analysis using a THz imaging system based on atomic vapour | |
Baianu | By Chemical-Hyperspectral Imaging, FT-IR/NIR, Vibro-Rotational Spectroscopy | |
Tseng | Long-wavelength Infrared Upconversion Spectroscopy and Imaging | |
Mahadevan-Jansen et al. | Steady State Fluorescence Spectroscopy for Medical Diagnosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200109 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200916 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201110 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210608 |